Nyu Langone Health
Clinical trials sponsored by Nyu Langone Health, explained in plain language.
-
Liver cancer combo trial stops early – too few patients to draw conclusions
Disease control TerminatedThis phase II trial tested whether adding either BMS-986253 or cabiralizumab to the immunotherapy nivolumab could shrink tumors better than nivolumab alone in people with advanced liver cancer. The study planned for 75 participants but was terminated after only 13 enrolled. Becau…
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
Saline mist and chest taps: a new combo for baby breathing trouble?
Symptom relief TerminatedThis study looked at whether giving infants with bronchiolitis a saltwater mist plus gentle chest tapping every 6 hours helps them get better faster. The trial included 75 children under 2 years old who were in the hospital and needed extra oxygen. Unfortunately, the study was st…
Phase: PHASE4 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 23, 2026 12:09 UTC
-
Tiny implant zaps nerves to boost stroke rehab
Knowledge-focused TerminatedThis study tested whether a small implanted device that stimulates the vagus nerve could improve arm and hand function in people who had a stroke at least a year ago. Four participants received either real or sham stimulation paired with physical therapy. The goal was to see how …
Phase: NA • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:55 UTC